Literature DB >> 26528897

Chronic intermittent hypoxia creates the perfect storm with calamitous consequences for respiratory control.

Ken D O'Halloran1.   

Abstract

Obstructive sleep apnoea syndrome (OSAS) is a common respiratory disorder with devastating consequences for integrative body systems. A picture is emerging to illustrate wide-ranging deleterious consequences of disordered breathing during sleep for major homeostatic control systems, with considerable interest in cardiorespiratory and autonomic morbidity underpinning the development of hypertension. The vista is bleak when one also considers the link between OSAS and a host of other maladies. Exposure to chronic intermittent hypoxia (CIH), resulting from repeated obstructions of the pharyngeal airway, is a hallmark feature of OSAS that appears, in animal models, to drive the development and maintenance of several key morbidities. A growing body of evidence now points to aberrant respiratory plasticity at multiple levels following exposure to CIH. Herein, we review the experimental data revealing that CIH causes: respiratory muscle weakness and fatigue; impaired motor control of the upper airway; and, discordant respiratory rhythm and pattern generation. This multifaceted conspiracy creates the perfect storm with the potential to exacerbate OSAS-serving to establish an inescapable cycle of respiratory morbidity. Several pharmacological interventions in animal models appear wholly effective in preventing the calamitous consequences of CIH and may have application as adjunctive therapies in the treatment of OSAS.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apnoea; Control of breathing; Oxidative stress; Respiratory muscles; Sleep-disordered breathing; Upper airway

Mesh:

Year:  2015        PMID: 26528897     DOI: 10.1016/j.resp.2015.10.013

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  8 in total

1.  The role of the Nox4-derived ROS-mediated RhoA/Rho kinase pathway in rat hypertension induced by chronic intermittent hypoxia.

Authors:  Wen Lu; Jing Kang; Ke Hu; Si Tang; Xiufang Zhou; Lifang Xu; Yuanyuan Li; Shuhui Yu
Journal:  Sleep Breath       Date:  2017-01-11       Impact factor: 2.816

2.  LKB1 is the gatekeeper of carotid body chemosensing and the hypoxic ventilatory response.

Authors:  Sandy MacMillan; Andrew P Holmes; Mark L Dallas; Amira D Mahmoud; Michael J Shipston; Chris Peers; D Grahame Hardie; Prem Kumar; A Mark Evans
Journal:  Commun Biol       Date:  2022-06-29

Review 3.  Respiratory muscle dysfunction in animal models of hypoxic disease: antioxidant therapy goes from strength to strength.

Authors:  Ken D O'Halloran; Philip Lewis
Journal:  Hypoxia (Auckl)       Date:  2017-07-14

4.  Chronic Intermittent Hypoxia Regulates CaMKII-Dependent MAPK Signaling to Promote the Initiation of Abdominal Aortic Aneurysm.

Authors:  Chenyu Xu; Jun Xu; Chunfang Zou; Qian Li; Shan Mao; Ying Shi; Yan Tan; Wei Gu; Liang Ye
Journal:  Oxid Med Cell Longev       Date:  2021-12-21       Impact factor: 6.543

5.  NADPH oxidase 2 is necessary for chronic intermittent hypoxia-induced sternohyoid muscle weakness in adult male mice.

Authors:  Sarah E Drummond; David P Burns; Sarah El Maghrani; Oscar Ziegler; Vincent Healy; Ken D O'Halloran
Journal:  Exp Physiol       Date:  2022-07-11       Impact factor: 2.858

6.  Effects of Gestational and Postnatal Exposure to Chronic Intermittent Hypoxia on Diaphragm Muscle Contractile Function in the Rat.

Authors:  Fiona B McDonald; Eugene M Dempsey; Ken D O'Halloran
Journal:  Front Physiol       Date:  2016-07-12       Impact factor: 4.566

Review 7.  AMPK and the Need to Breathe and Feed: What's the Matter with Oxygen?

Authors:  A Mark Evans; D Grahame Hardie
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 6.208

8.  Prebiotic administration modulates gut microbiota and faecal short-chain fatty acid concentrations but does not prevent chronic intermittent hypoxia-induced apnoea and hypertension in adult rats.

Authors:  Karen M O'Connor; Eric F Lucking; Thomaz F S Bastiaanssen; Veronica L Peterson; Fiona Crispie; Paul D Cotter; Gerard Clarke; John F Cryan; Ken D O'Halloran
Journal:  EBioMedicine       Date:  2020-08-30       Impact factor: 8.143

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.